Perigord adds €3m in funding to drive market dominance in life science regulatory artwork software

Dublin, Ireland, August 10^th, 2017. Perigord, a Dublin based company specialised in artwork solutions for the pharma and life science industries, recorded 100% growth last year in its software division. In 2017, the company is on track to exceed this figure and the BDO Development Capital Fund supports this growth with an investment of €3 million. This will bring the total investment to €5.4 million, since the first input made by the Fund in February 2016.

With two complementary divisions and a global office network in Europe, USA and Asia, Perigord will use the investment to facilitate international growth of their software product, GLAMS (Global Artwork Management System), as well as continue their supply of precision global artwork services to pharmaceutical and life science companies worldwide.

                                                          

Alan Leamy, CEO of Perigord, has ambitious plans for scaling the business and the recent investment will help the company to realise these goals. Perigord’s latest software is setting the global standard for management of artwork in the heavily regulated pharma and life science sectors.

Perigord currently have over 250 staff worldwide with centres in Europe, Asia and the USA, and their customer base has expanded to include nine of the world's top ten pharmaceutical companies.

Alan Leamy commented on the recent investment: “BDO Development Capital Fund’s investment has presented the company with a great opportunity to grow on a global scale. It will allow Perigord to service the rapidly expanding life sciences sector as it goes through significant changes and growth in the coming 5-year period. With this investment and the recent upsurge in demand for the product, Perigord are poised to unlock this growth and position itself as the dominant player in this heavily regulated sector.”

Sinead Heaney, Investment Director at the BDO Development Capital Fund, is delighted to be supporting Perigord at such a pivotal time: “The BDO Development Capital Fund supports businesses which demonstrate the ambition, capability and strategy to deliver global expansion and achieve market leading positions. This follow-on investment demonstrates how much potential we see for Perigord moving forward. They have the ambition, capability and strategy to become a leading player in this sector”.

 

On Saturday, April 1st, Perigord employees participated in the 'Bray 10KM Cliff Run'. This outdoor activity started in Greystones, and took us across the breath-taking cliff route to Bray.

Some weeks before the event, we had an informative and practical session offered by personal trainer Aaron Horan, who shared his experience and best practices to help us in our preparation.

The run was a huge success, and not only a wonderful opportunity to strengthen our team spirit and bring back more positive energy to our office, but a chance to raise funds that will be donated to a preferred charity at the end of this year. Perigord is known for organising different activities throughout the year to raise fund for charities.

Big thank you to all who took part in making 'Bray 10KM Cliff Run' another successful day out for Perigord! We are very proud of your achievement!

Perigord sponsored and attended the '5th Annual Pharma Labeling Compliance Conference' on March 29-30, 2017 in Boston, USA.

This important event brought together pharma industry thought-leaders and specialists from companies across the globe to explore the emerging challenges and regulatory trends through presentations, discussions and networking. This year, the key topics of the conference were:

• Developing an agile and actionable labelling strategy to prepare for the regulatory changes and the evolving industry requirements.
• Creating a robust end-to-end tracking system to centralise labelling.
• Comparing and contrasting pharma and medical device labelling to maximise efficiency across industries.
• Incorporating human factor data in the label to improve product literacy.

 

We are very proud of our Global Quality Director; Suzanne Ivory, who presented and shared her expert knowledge on solutions to optimise end-to-end artwork processes. As the challenge to provide adequate artwork becomes more complex and the need for artwork management systems becomes more critical, we believe that sharing our expertise will help pharmaceutical labelling leaders to find innovative solutions to these challenges.

 

This has been another successful year for the 'Annual Pharma Labeling Compliance Conference' and we are already looking forward to next year!

Perigord Acquires Pharma International

•  Positions for rapid growth in North and South America
•  Expands services to better serve its labeling artwork customers in the life science sector 
•  CEO of Pharma International will join Perigord in executive capacity as part of our Global Leadership Team 
•  Combined number of pharma/medical device customers grows to 30, ranging from emerging and midsized companies to    the world’s largest  

Perigord partners with GlobalVision to integrate artwork management solutions.

Dublin, Ireland, September 7, 2016.

Perigord, innovators in Life Science Artwork Management Services and Solutions, and GlobalVision, leaders in the design and delivery of Innovative Proofreading Technologies, today announced their alliance for the integration of their artwork management systems in order to better service the Life Science Industries.

Perigord, recognising the value of working with GlobalVision, who have over 25 years’ experience in proofreading, has entered this strategic collaboration to enable seamless integration of GlobalVision’s Proofware software into their GLAMS (Global Artwork Management System) solution, resulting in streamlined exchanges and decreased time to market in the artwork processes.

Perigord’s GLAMS is a Configurable Off the Shelf (COTS) solution for Artwork Management that meets the current and future needs of Life Science customers.  GlobalVision’s Proofware brings an advanced suite of application tools focused on delivering accuracy and traceability for Quality Control, reducing artwork rework cycles and cost. Through the integration of these software management systems, the user will benefit from quicker file comparisons during proofreading, improved quality control and earlier error detection.  In addition, both systems facilitate 21 CFR Part 11 compliance to electronic records and electronic signature rules.

"We are excited to team with GlobalVision as they, like us, are specialists in the Life Science Industries and understand the GMP environment”, says Alan Leamy, CEO Perigord.  “As one of our new partners, GlobalVision represent our belief that the future of artwork management through the lifecycle process requires integrated automated technologies as a necessity of providing accurate artwork to market, on time and right first time.”

Jonathan Hou, Director of Technology at GlobalVision, also comments: “At GlobalVision, we are looking forward to the synergy this strategic partnership can bring to current and future clients, and we recognize that Perigord’s business mission fits very well with that of our Life Science focus.”

About Perigord

Perigord are specialists in the provision of artwork and labelling outsource services and management solutions to the Life Science Industries globally. Perigord’s unique combination of offerings and technical expertise, coupled with our ability to continually deliver Right First Time artwork, offers the Life Science Industries the perfect solution for outsourced artwork production.

Perigord’s flagship software product GLAMS (Global Artwork Management Software) is a web-based Life Science Artwork Management Solution, developed and designed to control and manage artwork through the artwork lifecycle. 

Contact

Mark Ennis

Contact Us

About GlobalVision

GlobalVision is the world leader in the design of innovative proofreading technologies. With over 25 years of experience, we've helped customers increase proofreading accuracy, efficiency, and speed. Our solutions have been integrated into the packaging workflows of leading consumer packaged goods companies, printing firms and over 70% of the top pharmaceutical companies worldwide.

Contact

Michael Malz

Contact GlobalVision

Perigord partners with Nathean to provide Life Science Artwork Management Software customers with increased levels of performance and superior data-driven decisions.

Dublin, Ireland, 21 June 2016.

Perigord, the global leader in Life Science artwork management services and solutions, recently entered a strategic partnership with data analytics and reporting company Nathean to provide Logix, their Business Intelligence and enhanced KPI Reporting tool, as an integrated feature within Perigord’s Global Artwork Management System (GLAMS).

Life Science companies are constantly facing challenges with the agile and secure management of digital artwork assets and this has become a key strategic focus following the recent increase in mergers and acquisitions.

The partnership between Perigord and Nathean offers Life Science artwork management software customers actionable analytics, granting the capture of extensive amounts of information in easy to view dashboards, tailored views and automated email reports, previously unseen as part of an artwork management software solution.

Speaking of the partnership, Perigord’s Head of Professional Services, Sam Cole says “Perigord are very pleased to work with Nathean to provide informed decision making and planning through our GLAMS Analytics tool.  The Business Intelligence and enhanced KPI Reporting feature provides configurable reporting dashboards enabling faster analysis and reporting, offering GLAMS customers the benefits of deeper and richer business insights. A system such as this which presents visibility and reporting of live artwork data is exactly what our customers have been requesting and we are delighted to now be in a position to offer this as part of our GLAMS offering.”

Maurice Lynch, CEO of Nathean, also comments on the co-operation between Perigord and Nathean noting “Working with a well-established global Life Science partner such as Perigord allows Nathean the opportunity to assist their GLAMS customers by offering an increased return on investment.  By implementing the Business Intelligence and enhanced KPI Reporting feature, GLAMS customers are allowed autonomous and uniformed decision making for all users.”

About Perigord

Perigord are specialists in the provision of artwork and labelling outsource services and management solutions to the Life Science Industries globally. Perigord’s unique combination of offerings and technical expertise, coupled with our ability to continually deliver Right First Time artwork, offers the Life Science Industries the perfect solution for outsourced artwork production.

Perigord’s flagship software product GLAMS (Global Artwork Management Software) is a web-based Life Science Artwork Management Solution, developed and designed to control and manage artwork through the artwork lifecycle. 

Contact

Barbara Murphy

Marketing Manager

Contact Us

About Nathean

Nathean develops Logix, a ground breaking self-service Analytics & Reporting platform designed to effortlessly connect people and information. Every day Logix enables people to discover actionable insights from data helping drive better business outcomes.

Contact

Maurice Lynch

CEO

Contact Nathean

The number of pharmaceutical product recalls are growing. Some estimates show that over 50% of recalls are related to pharmaceutical packaging artwork and labelling.

How many times have we heard these statistics over the last 20 years? And yet nothing changes.

The bottom line is that if there is an error with pharmaceutical artwork, the patient can die. The absence of regulatory requirements within the pharmaceutical industry regarding the production of artwork is indicative of the lack of focus often given to this process.

There is increased pressure to improve operational performances and reduce the level of human error. If we make it easy for someone to make a mistake, they will. We need to make it easy to get it right first time.

To do this we have to take a realistic look at the challenges faced by the pharmaceutical industry over the next five to ten years which will impact the artwork process and determine what robust innovative measures we should take to ensure these recall figures don’t spiral out of control.

Attitudes towards artwork management within the supply chain need to change. There should be a focus on quality driven systems to enable continuous technological developments facilitate the automation and standardisation required to prevent mistakes.

Industry analysis

Firstly we need to look at some of the key aspects of the pharmaceutical industry that are driving change.

1. Mergers & Acquisitions in the healthcare sector set a new record in 2015 of $724 billion. As a result, the agile and secure management of digital artwork assets has become a key strategic focus. 

2. Serialisation will result in a combination of more artwork content and stricter directives governing readability. This combined with reduced print space will drive an unprecedented demand for regulated artwork services and management systems over the next 5 years. 

3. Product proliferation leads to significantly increased frequency of artworking events and far greater complexities in managing the artworking processes with many companies having reached or exceeded their capability to manage the process internally. 

4. As a result of the patent cliff, a single innovative pharmaceutical product which has lost patent protection is being replaced with new generic products globally, leading to an exponential growth in demand for outsourced artwork solutions. 

What needs to be done?

Why do we accept high levels of inaccuracy when we can standardise how artwork is created and automate how it’s managed?

Pharmaceutical companies need to understand how their present artwork processes should change to facilitate these future drivers. To navigate accurately through these changes a proactive and systematic approach to artwork is crucial. Companies have to ask themselves if the artwork process is clearly defined, optimised and quality driven.

Managing artwork for the pharmaceutical industry is a very specialised, niche service which can only be properly controlled by a GMP compliant partner. If using a vendor, it is critical to develop a partnership to ensure all aspects of the artwork supply chain are controlled and agile to meet the challenges of the industry.

The two fundamental areas which need to be addressed are the physical production of the artwork and the management of the artwork process.

Artwork production 

Perigord recommends a one touch process in building compliant artwork which increases efficiency, reduces costs and minimises risk through fewer stages, thus eliminating the historical prepress stage. Effectively this means that artwork is built to high quality standards (and print ready) and the layer structure and font integrity is maintained throughout the approval cycle. Perigord ensures this process sits in a robust quality management system with a change management procedure that facilitates the efficiencies to be gained through the introduction of automated technology. 

Artwork management systems 

The most obvious way to remove the dangers of human error is to automate. Managing the amount of stakeholders and the input they have in this complex process by email is inconsistent with every company’s objective of getting product to market on time and right first time. This needs to be replaced by a highly configurable system that can be easily adapted to align with a customer's current and future processes, giving the flexibility of a systematic approach to managing products and product related information. 

In summary, reducing the number of recalls in the pharmaceutical industry requires better regulation, improved operational procedures and a change of attitude towards artwork production and management. The challenges that lie ahead have been identified, all we need now is to face them head on, in a controlled GMP fashion.

References

1 - http://www.xtalks.com/Pharmaceutical-Packaging-Management.ashx

2 - http://news.yahoo.com/global-mergers-acquisitions-volume-hits-record-2015-163303085.html 

Dublin, Ireland, 31 March, 2016.

Perigord has officially launched the latest release of their proprietary innovative software, GLAMS (Global Artwork Management System).  GLAMS 4,  a configurable Software as a Service (SaaS) solution, presents a comprehensive artwork lifecycle management offering, coupled with fully integrated web forms and Business Intelligence Reporting capabilities.

Giving all stakeholders and customers in the artwork management process full control, by linking them through automatic emails and alerts, GLAMS 4’s end-to-end digital workflow allows customers to intelligently search and quickly distribute their artwork assets.

GLAMS - Connecting Stakeholders

GLAMS 4 offers a platform for multiple modules and, as it is web based, it is a light touch application, providing future proofed software for Life Science customers.

Keeping the Life Science customer in mind, GLAMS 4 has been developed in compliance with GAMP 5 guidelines, is fully validated and allows 24/7 global access. In addition and in order to deliver a unified environment, GLAMS 4 can be seamlessly integrated to existing ERP/PLM systems.

Speaking of the launch, Perigord’s Head of Professional Services, Sam Cole says “We are delighted to be in a position to launch GLAMS 4. This web based artwork management solution is ready and available to be rolled out in both existing and future GLAMS customers. Our platform is a Configurable Off The Shelf (COTS) solution, enabling exciting upgrades in the future for all customers.

About Perigord

Perigord are specialists in the provision of artwork and labelling outsource services and management solutions to the Life Science Industries globally. Perigord’s unique combination of offerings and technical expertise, coupled with our ability to continually deliver Right First Time artwork, offers the Life Science Industries the perfect solution for outsourced artwork production.

Perigord’s flagship software product GLAMS (Global Artwork Management Software) is a web-based Life Science Artwork Management Solution, developed and designed to control and manage artwork through the artwork lifecycle. 

Contact

Barbara Murphy

Marketing Manager

Contact Us

Dublin, Ireland, 12 February 2016.

Perigord, a leader in the European life science packaging artwork management sector, today announced it has secured a development capital investment from the BDO Development Capital Fund to accelerate the company’s global expansion.  With the life sciences sector now facing post patent cliff complexities (including unprecedented M&A activity, generic drug proliferation and product serialisation to combat counterfeiting) the pharma packaging sector will witness significant growth in the coming 5 year period. 

From L-R: Andrew Bourg (left), Investment Director, Development Capital, Sinead Heaney, Investment Director, Development Capital, Alan Leamy (right),  CEO, Perigord

Employing over 100 people, Perigord is aiming to lead new developments in the sector.  From its base in Dublin, which services the European market, Perigord plans to upgrade and open the new hubs in America, Asia and Latin America.  This world-wide footprint will facilitate the creation of a global platform to service the life sciences sector and deliver true global solutions. 

The funding for Perigord was secured from the BDO Development Capital Fund, a fund supported by Enterprise Ireland (an Irish Government Agency), Bank of Ireland and leading Irish Corporates CRH, Glanbia and Glen Dimplex. The Fund invests development and growth capital in ambitious companies to support their export growth plans. The funding will be used to build out Perigord’s global network and respond to existing demand to provide artwork solutions under global supply agreements.

Perigord has a clear plan to realise its ambition to globalise the company and achieve a dominant market share in the highly regulated sector in which it operates.  Competing against multinational competitors, Perigord has successfully built strong relationships with many of the world’s leading global pharmaceutical businesses and the company’s sole focus on the pharma and life sciences industry has enabled it to achieve a compelling competitive market position.

Speaking about the company’s plans, Perigord CEO, Alan Leamy said:

"This investment from the BDO Development Capital Fund will enable us to build on the success achieved to date which is thanks to our team of highly talented & committed people in Perigord, the external support of Enterprise Ireland and the support of our customers.  We look forward to working with our new partners in Development Capital to increase our global scale and service the global life sciences sector as it goes through significant changes in the coming 5 year period.

We have a proven track record with some of the world’s leading pharma companies and we can now build on our European success with expansion right across the world."

Also speaking was Sinead Heaney, Investment Director, Development Capital, who said:

"The BDO Development Capital Fund supports businesses which demonstrate the ambition, capability and strategy to deliver global expansion and achieve market leading positions. Perigord has all these qualities and we look forward to our partnership to assist them achieve their international expansion plans."

Helen Ryan, former CEO of Creganna who is an Advisory Panel Member of the BDO Development Capital Fund also commented

"Perigord is an excellent example of the type of company the fund is seeking to support. The life science sector is experiencing significant growth and we look forward to working with Perigord to unlock this growth potential by assisting the company to build a truly global network."

Contact

 

Barbara Murphy

Marketing Manager

Contact Us

Dublin, Ireland, December 9, 2015.

Perigord, the global leader in Life Science artwork solutions, recently appointed Sam Cole as their Head of Professional Services.

Cole, who previously worked for Schawk’s software division, Blue Software, as their Consulting Services Manager EMEA, joined Perigord in October as Head of Professional Services and will be responsible for overseeing the GLAMS (Global Artwork Management System) software department.  GLAMS modular system connects all the stakeholders in a customer’s artwork production process including new products, engineering, purchasing, marketing and external contract vendors.

We are delighted to welcome Sam on board,’ said Paul Leamy, CTO. “His consulting, process mapping and configuration experience coupled with his previous excellent track record as a senior manager in Schawk, will prove an integral link between Perigord’s software division and our customers. Perigord look forward to working with him to promote GLAMS as the number 1 Life Science Artwork Management Solution.”

Cole recognises the challenges for Artwork Management Solutions particularly from the perspective of regulatory requirements as well as technology and innovation advancements and understands that at Perigord customer service is of the utmost importance.

“Moving to Perigord represents an exceptional opportunity for me, in particular at this time of development and expansion,” said Cole.  “I am excited and happy to be part of the substantial growth taking place in Perigord, by working with the GLAMS team to bring our flagship product to the next level. Perigord’s focus on the Life Science sector is second to none and my mission is to apply my regulatory industry knowledge to the end-to-end digital workflow management in order to cement these relationships.”

 

About Perigord

Perigord’s flagship software product GLAMS (Global Artwork Management Software) is a web-based Life Science Artwork Management Solution, developed and designed to control and manage artwork through the artwork lifecycle.  Connecting all stakeholders in the process, GLAMS has been developed to GAMP 5 standards, is fully validatable and allows 24/7 global access.

Perigord are specialists in the provision of artwork and labelling outsource services and management solutions to the Life Science Industries globally.  Perigord’s unique combination of offerings and technical expertise, coupled with our ability to continually deliver Right First Time artwork, offers the Life Science Industries the perfect solution for outsourced artwork production.

www.perigord-as.com

 

Contact

 

Barbara Murphy

Marketing Manager

Contact Us